Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Toxicol Ind Health ; 27(10): 873-8, 2011 Nov.
Article En | MEDLINE | ID: mdl-21505009

Paraoxonase (PON1) is a serum esterase responsible for the protection against xenobiotics toxicity such as paraoxon. Alterations in PON1 concentrations have been reported in a variety of diseases including diabetes mellitus (DM). It has been shown that the serum PON1 concentration and activity are decreased in patients with both type 1 and type 2 DM. This study aimed to investigate the lipid profiles and the relationship between PON1 activity and PON1, QR192 and LM55 polymorphisms in Turkish type 2 diabetic patients and non-diabetic control subjects. According to our results, RR variant had significantly higher PON activity than QQ and QR variants (p < 0.01) and LL variant had significantly higher PON activity than MM variant in both control and patient groups (p < 0.05). In conclusion, we found that PON1 192RR and 55LL genotypes are associated with higher PON activity than QQ and MM genotypes. This may be more protective to lipid peroxidation.


Aryldialkylphosphatase/genetics , Diabetes Mellitus, Type 2/genetics , Polymorphism, Single Nucleotide , Adult , Aryldialkylphosphatase/blood , Diabetes Mellitus, Type 2/blood , Female , Genotype , Humans , Lipid Peroxidation , Lipids/blood , Male , Middle Aged
...